EyeGene,Inc
Develops gene/cell therapies for age-related diseases and preventive vaccines.
185490 | KO
Overview
Corporate Details
- ISIN(s):
- KR7185490000
- LEI:
- Country:
- South Korea
- Address:
- 경기도 의왕시 양지편2로 13 2층, 의왕시
- Website:
- https://eyegene.co.kr/en/
Description
EyeGene, Inc. is a clinical-stage biopharmaceutical company that researches and develops innovative therapeutics, with a primary focus on gene and cell therapy for age-related diseases. The company's pipeline includes EG-Mirotin, a treatment candidate for non-proliferative diabetic retinopathy and dry age-related macular degeneration. EyeGene is also developing preventive vaccines, such as EG-HPV for cervical cancer, utilizing its proprietary EG-Vac adjuvant system to enhance vaccine efficacy. The company is dedicated to creating transformative treatments by advancing biomedical science.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-11-28 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 83.2 KB | ||
| 2023-11-23 00:00 |
투자판단관련주요경영사항(임상시험계획변경승인)(mRNA 기반 코로나-19 예방 다가백신 '이지-코브투(EG-COVII)' 호주 임상 제1/2a상…
|
Korean | 14.6 KB | ||
| 2023-11-14 00:00 |
분기보고서 (2023.09)
|
Korean | 1.2 MB | ||
| 2023-11-13 00:00 |
투자판단관련주요경영사항(임상시험계획변경승인신청)( mRNA 기반 코로나-19 예방 다가백신 '이지-코브투(EG-COVII)' 호주 임상 제1/…
|
Korean | 13.6 KB | ||
| 2023-10-24 00:00 |
투자판단관련주요경영사항(임상시험계획승인신청등결정)(mRNA 기반 코로나-19 예방 다가백신 '이지-코브투(EG-COVII)' 호주 임상 제1/…
|
Korean | 12.6 KB | ||
| 2023-10-10 00:00 |
투자판단관련주요경영사항(임상시험계획승인신청)(mRNA 기반 코로나-19 예방 다가백신 '이지-코브투(EG-COVII)' 호주 임상 제1/2a상…
|
Korean | 10.2 KB | ||
| 2023-09-22 00:00 |
투자판단관련주요경영사항(임상시험결과)(심근허혈 및 재관류 손상 치료후보물질'이지-마이오신(EG-Myocin)' 임상2상시험 결과)
|
Korean | 13.4 KB | ||
| 2023-09-22 00:00 |
주식매수선택권부여에관한신고
|
Korean | 15.9 KB | ||
| 2023-09-12 00:00 |
투자판단관련주요경영사항(임상시험결과)(mRNA 기반 코로나-19 예방백신 (EG-COVID) 국내 임상 제 1상 시험 결과)
|
Korean | 29.4 KB | ||
| 2023-08-14 00:00 |
반기보고서 (2023.06)
|
Korean | 1.0 MB | ||
| 2023-07-24 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 83.2 KB | ||
| 2023-07-07 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 83.5 KB | ||
| 2023-06-16 00:00 |
신주인수권부사채(해외신주인수권부사채포함)발행후만기전사채취득(제2회차)
|
Korean | 10.5 KB | ||
| 2023-05-15 00:00 |
분기보고서 (2023.03)
|
Korean | 972.3 KB | ||
| 2023-05-03 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 83.6 KB |
Automate Your Workflow. Get a real-time feed of all EyeGene,Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for EyeGene,Inc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for EyeGene,Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
